The AIDS2022 conference held recently in Montreal, Canada highlighted yet again the need for community activism and the importance of involving young people, writes Dr Yogan Pillay. He argues that the youth and communities must be engaged in the conceptualisation and writing of South Africa’s new AIDS plan, and young people and community-based organisations must have a central role in key aspects of its implementation.
Over the last three decades, Dr Fareed Abdullah has been at the coalface of South Africa’s response to HIV, tuberculosis, and more recently, COVID-19. Biénne Huisman chatted with Abdullah about providing antiretrovirals in the time of AIDS denialism, National Health Insurance, working as a medical doctor, and the toll HIV has sadly taken on his own family.
New child-friendly formulations of several important antiretroviral medicines were recently approved by the South African Health Products Regulatory Authority. Thabo Molelekwa asks what this means for children living with HIV in South Africa and how long it will take for these medicines to become widely available.
In 2021, HIV was successfully suppressed in the bodies of around 63% of the close to eight million people living with HIV in South Africa. This is according to recent outputs from Thembisa, the leading mathematical model of HIV in South Africa. With the help of some graphs, Spotlight editor Marcus Low unpacks this and other key model outputs.
Special youth clinics appear to be an effective means of providing healthcare services to young people who otherwise might not engage with healthcare services. But is building more youth clinics realistic given our resource constraints, or is it better to focus on making ‘normal’ clinics more youth-friendly – or should we be looking beyond clinic-based healthcare services altogether? Tiyese Jeranji investigates.
The community-led clinic monitoring project, Ritshidze last week, released its follow-up report on the state of (primary) healthcare in Mpumalanga. There were some improvements, but patients are still waiting over four hours to be seen at some clinics. Nthusang Lefafa unpacks some of the report’s findings and asked the health department about its plans to address these shortcomings.
In 2019, the Department of Health started providing the antiretroviral drug dolutegravir as part of HIV treatment in the public sector. Three years later, close to 3.2 million people in South Africa are taking dolutegravir every day. Even so, the rollout of dolutegravir hasn’t all been smooth sailing. Elri Voigt investigates how the massive undertaking of switching millions of people to a new drug has gone.
The National Department of Health says that lubricant should be freely available alongside condoms at clinics around the country. But according to community-led monitoring group Ritshidze, clinics often do not offer lubricant. Biénne Huisman reports on why access to lubricant is important for HIV prevention and why oil-based lubricants should not be used with condoms.
South Africa’s new National Strategic Plan for HIV, TB, and STIs is being developed this year. Spotlight editor Marcus Low asks what we should aim for in the new strategy and how we should go about developing it.
The South African Health Products Regulatory Authority recently approved the use of the monthly dapivirine vaginal ring for women 18 years and older to reduce the risk of HIV infection. Thabo Molelekwa looks at the evidence for the ring’s efficacy and asks what plans there are for making it available to women in South Africa.
Broadly neutralising antibodies (bnAbs) are one of the most active and exciting areas in HIV research. Last year Spotlight reported on a “proof of concept” study showing that a specific bnAb can successfully prevent infection with certain strains of HIV. Now, we also have intriguing findings suggesting that bnAbs may have a role to play in the treatment of HIV in children. Elri Voigt reports.
HIV and ageing were one of the hot topics at the recently held Conference on Retroviruses and Opportunistic Infections. Elri Voigt reports.